Back to results
US 2002/0054911 A1Published application
Novel oral dosage form for carvedilol
AssigneeBoehringer Mannheim Pharmaceutical Corporation-Sm ithKline Beckman Corporation, Limited Partnershi
InventorChoon K. Oh
Life of this patent
Estimating the term…
Abstract
The present invention discloses a matrix formulation containing carvedilol.
Claims8
A matrix formulation comprising carvedilol in an oral dosage unit form.
An enteric coated formulation comprising carvedilol in an oral dosage unit form.
A method of treating hypertension, angina, or congestive heart failure which comprises administering carvedilol in a matrix formulation.
A method of treating hypertension, angina, or congestive heart failure which comprises administering carvedilol in an enteric coated formulation.
Dependencies are inferred from the claim text.